Analysis of SARS-CoV-2 Spike Protein As The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study. J. Trop. Pharm. Chem 2021, 5 (4), 347-352. https://doi.org/10.30872/j.trop.pharm.chem.v5i4.257.